In this study we systematically reviewed outcomes in recipients and donors of commercial kidney transplants. Inherent in a study of this nature is the possibility of center and country bias, in particular there are no publications from China and South America. Publications also tended to report poor outcomes which may reflect bias on the part of the authors or to highlight the ethical issues in this area. We were unable to perform a meta-analysis due to variability in studies making it impossible to synthesize the data other than descriptive. Furthermore, these studies were not large or well conducted. We found that patient and graft survival was generally inferior to the data obtained from the UNOS (United Network for Organ Sharing). Some studies did achieve good outcomes, however, due to lack of details, it was not possible to infer if the donor hospital, surgical technique or immunosuppressive regimen was a factor. There was a higher incidence of unconventional and life-threatening infections such as malaria, invasive fungal infections, pneumonia, HIV and hepatitis. There was also a markedly increased incidence of postoperative surgical interventions in recipients. We suggest the establishment of a database for both recipients and donors to identify unique surgical, medical, infectious and immunosuppressive protocols for the recipients and donors in these hospitals. This could lead to better liaison between the recipient and donor hospitals so that modern surgical and medical practices can be implemented. There should also be improved emotional and psychological support to both the recipient and the donor. However, these steps could be seen as condoning the reprehensible practice of commercialization of human body parts.

Keywords:
Commercial kidney transplants, Commercial transplants, risks, Kidney transplantation, literature search, Kidney transplants, outcomes in recipients and donors, Medical tourism
1.
Chugh KS, Jha V: Commerce in transplantation in third world countries. Kidney Int 1996;49:1181–1186.
2.
Davidson AM: Commercialization in organ donation. Nephrol Dial Transplant 1994;9:348–349.
3.
Bramstedt KA, Xu J: Checklist: passport, plane ticket, organ transplant. Am J Transplant 2007;7:1698–1701.
4.
Walsh D: Transplant tourists flock to Pakistan, where poverty and lack of regulation fuel trade in human organs. The Guardian [online]. Accessed September 27, 2007.
5.
Commercialization in transplantation: the problems and some guidelines for practice. The Council of the Transplantation Society. Lancet 1985;28:715–716.
6.
Osterweil N: Black market kidney surgery offers no guarantees. MedPage [online]. Accessed September 27, 2007.
8.
Frontline: India’s national magazine. http://www.hinduonnet.com/fline/fl1425/14250640.htm
10.
Sun CY, Lee CC, Chang CT, Hung CC, Wu MS: Commercial cadaveric renal transplant: an ethical rather than medical issue. Clin Transplant 2006;20:340–345.
11.
Morad Z, Lim TO: Outcome of overseas kidney transplantation in Malaysia. Transplant Proc 2000;32:1485–1486.
12.
Prasad GV, Shukla A, Huang M, D’A Honey RJ, Zaltzman JS: Outcomes of commercial renal transplantation: a Canadian experience. Transplantation 2006;82:1130–1135.
13.
Canales MT, Kasiske BL, Rosenberg ME: Transplant tourism: outcomes of United States residents who undergo kidney transplantation overseas. Transplantation 2006;82:1658–1661.
14.
Inston NG, Gill D, Al-Hakim A, Ready AR: Living paid organ transplantation results in unacceptably high recipient morbidity and mortality. Transplant Proc 2005;37:560–562.
15.
Higgins R, West N, Fletcher S, Stein A, Lam F, Kashi H: Kidney transplantation in patients traveling from the UK to India or Pakistan. Nephrol Dial Transplant 2003;18:851–852.
16.
Kennedy SE, Shen Y, Charlesworth JA, et al: Outcome of overseas commercial kidney transplantation: an Australian perspective. Med J Aust 2005;182:224–227.
17.
Frishberg Y, Feinstein S, Drukker A: Living-unrelated (commercial) renal transplantation in children. J Am Soc Nephrol 1998;9:1100–1103.
18.
Friedlaender MM, Gofrit O, Eid A: Unrelated-living-donor kidney transplantation. Lancet 1993;342:1061.
19.
Erikoğlu M, Tavli S, Tonbul Z: Ethical and economical appreciation of living nonrelated donors renal transplantation from outside Turkey. Transplant Proc 2004;36:1253–1254.
20.
Sever MS, Kazancioğlu R, Yildiz A, et al: Outcome of living-unrelated (commercial) renal transplantation. Kidney Int 2001;60:1477–1483.
21.
Sever MS, Ecder T, Aydin AE, et al: Living-unrelated (paid) kidney transplantation in third world countries: high risk of complications besides the ethical problem. Nephrol Dial Transplant 1994;9:350–354.
22.
Ivanovski N, Popov Z, Cakalaroski K, Masin J, Spasovski G, Zafirovska K: Living-unrelated (paid) renal transplantation – ten years later. Transplant Proc 2005;37:563–564.
23.
Ivanovski N, Stojkovski L, Cakalaroski K, Polenakovic M: Living-unrelated (paid) renal transplantation: besides the ethics. Transplant Proc 1997;29:3631.
24.
Qunibi W, DeVol E, Al-Gain S, et al: Commercially motivated renal transplantation: results in 540 patients transplanted in India. The living non-related renal transplant study group. Clin Transplant 1997;11:536–544.
25.
Mansy H, Khalil A, Aly TF, et al: Outcome of commercial renal transplantation: two years follow-up. Nephron 1996;74:613–616.
26.
Ghods AJ, Savaj S: Iranian model of paid and regulated living-unrelated kidney donation. Clin J Am Soc Nephrol 2006;1:1136–1145.
27.
Ghods AJ: Renal transplantation in Iran. Nephrol Dial Transplant 2002;17:222–228.
28.
Ben Hamida F, Ben Abdallah T, Goucha R, et al: Outcome of living-unrelated (commercial) renal transplantation: report of 20 cases. Transplant Proc 2001;33:2660–2661.
29.
Hussein MM, Mooij JM, Roujouleh H, el-Sayed H: Commercial living nonrelated renal transplantation: observations on early complications. Transplant Proc 1996;28:1941–1944.
30.
Colakoglu M, Yenicesu M, Akpolat T, et al: Nonrelated living-donor kidney transplantation: medical and ethical aspects. Nephron 1998;79:447–451.
31.
Al-Shohaib S: Organ trading: a medical or ethical mistake? Nephron 1996;73:106.
32.
Odum J, Rylance PB, Jackson MA: From Wolverhampton to Bombay. Lancet 1994;343:734.
33.
Onwubalili JK, Obineche EN, Assuhaimi S, Bassiouni M: Outcome of bought living non-related donor kidneys followed up at a single centre. Transpl Int 1994;7:27–32.
34.
Kazim E, al-Rukaimi M, Fernandez H, Raizada SN, Mustafa MJ, Huda NE: Buying a kidney: the easy way out? Transplant Proc 1992;24:2112–2113.
35.
Abouna GM, Kumar MS, Samhan M, Dadah SK, John P, Sabawi NM: Commercialization in human organs: a Middle Eastern perspective. Transplant Proc 1990;22:918–921.
36.
Salahudeen AK, Woods HF, Pingle A, et al: High mortality among recipients of bought living-unrelated donor kidneys. Lancet 1990;336:725–758.
37.
Al-Khader AA, al-Sulaiman M, Dhar JM: Living non-related kidney transplantation in Bombay. Lancet 1990;336:1002.
38.
Abu-Romeh SH, Osman N, Rashid A: Living non-related kidney transplantation in Bombay. Lancet 1990;336:1584.
39.
Naqvi SA, Ali B, Mazhar F, Zafar MN, Rizvi SA: A socioeconomic survey of kidney vendors in Pakistan. Transpl Int 2007;20:934–939.
40.
Goyal M, Mehta RL, Schneiderman LJ, Sehgal AR: Economic and health consequences of selling a kidney in India. JAMA 2002;288:1589–1593.
41.
Zargooshi J: Quality of life of Iranian kidney ‘donors’. J Urol 2001;166:1790–1799.
42.
Zargooshi J: Iranian kidney donors: motivations and relations with recipients. J Urol 2001;165:386–392.
43.
Thiagarajan CM, Reddy KC, Shunmugasundaram R, et al: The practice of unconventional renal transplantation at a single center in India. Transplant Proc 1990;22:912–914.
44.
Psst, wanna buy a kidney? Economist.November 16, 2006.
45.
Griffin A: Kidneys on demand. BMJ 2007;334:502–505.
46.
Rohter L: The organ trade: a global black market; tracking the sale of a kidney on a path of poverty and hope. New York Times. Published May 23, 2004.
47.
Laino C: Going abroad for transplants has risks. WebMD Medical News [online]. Accessed September 27, 2007.
48.
Kandel P: India: The kidney bazaar. Lancet 1991;337:1534.
49.
Baines LS, Jindal RM: Consequences of selling kidneys in India. JAMA 2003;289:697–700.
50.
World Health Organization: Guiding principles on human organ transplantation. Lancet 1991;337:1470–1471.
51.
Spital A, Taylor JS: Living organ donation: always ethically complex. Clin J Am Soc Nephrol 2007;2:203–204.
52.
Coalition for organ-failure solutions. http://www.cofs.org/what.htm
53.
Demand soars on kidney transplant market. http://archive.newsmax.com/archives/articles/2007/4/3/143617.shtml
54.
Sajjad I, Baines LS, Salifu M, Jindal RM: The dynamics of recipient-donor relationships in living kidney transplantation. Am J Kidney Dis 2007;50:834–854.
55.
Joseph JT, Baines LS, Morris MC, Jindal RM: Quality of life after kidney and pancreas transplantation: a review. Am J Kidney Dis 2003;42:431–445.
56.
Twilight trade. http://www.hindustantimes.com. Published February 6, 2008.
57.
Kidney thefts shock India. New York Times. Published January 30, 2008.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.